CAPTRUST Financial Advisors
RARE icon

CAPTRUST Financial Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

CAPTRUST Financial Advisors’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
32,122
+11,727
+57% +$291K ﹤0.01% 1713
2026
Q1 		$427K Buy
20,395
+9,017
+79% +$203K ﹤0.01% 2140
2025
Q4 		$262K Buy
11,378
+2,358
+26% +$77.5K ﹤0.01% 2348
2025
Q3 		$271K Buy
+9,020
New +$271K ﹤0.01% 2240
2024
Q4 		– Sell
-11,428
Closed -$635K – 2380
2024
Q3 		$635K Buy
11,428
+6,445
+129% +$328K ﹤0.01% 1453
2024
Q2 		$205K Buy
+4,983
New +$213K ﹤0.01% 2028
2024
Q1 		– Sell
-21,560
Closed -$1.03M – 2545
2023
Q4 		$1.03M Sell
21,560
-1,748
-7% -$67.8K ﹤0.01% 1248
2023
Q3 		$831K Sell
23,308
-1,532
-6% -$60.7K ﹤0.01% 1311
2023
Q2 		$1.15M Buy
+24,840
New +$1.15M ﹤0.01% 1125
2022
Q3 		– Sell
-404
Closed -$24K – 3586
2022
Q2 		$24K Buy
404
+145
+56% +$8.92K ﹤0.01% 3272
2022
Q1 		$19K Buy
259
+11
+4% +$765 ﹤0.01% 3423
2021
Q4 		$21K Buy
248
+114
+85% +$9.28K ﹤0.01% 3258
2021
Q3 		$12K Sell
134
-6
-4% -$542 ﹤0.01% 3504
2021
Q2 		$13K Sell
140
-534
-79% -$55.6K ﹤0.01% 3392
2021
Q1 		$77K Buy
674
+133
+25% +$18.1K ﹤0.01% 2139
2020
Q4 		$75K Buy
+541
New +$64.2K ﹤0.01% 1651

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

CAPTRUST Financial Advisors's RARE Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Ultragenyx Pharmaceutical (RARE) stake by 57% in Q2 2026, buying an estimated $291K and bringing the position to 32,122 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1713.

CAPTRUST Financial Advisors first reported a position in RARE in Q4 2020 and has held it in 16 quarters since. The position peaked at $1.15M in Q2 2023. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • CAPTRUST Financial Advisors held 32,122 shares of Ultragenyx Pharmaceutical worth $1.07M as of Q2 2026.
  • CAPTRUST Financial Advisors bought 11,727 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $291K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1713 holding.
  • CAPTRUST Financial Advisors first reported a position in Ultragenyx Pharmaceutical in Q4 2020 and has held it in 16 quarters since.
  • CAPTRUST Financial Advisors's Ultragenyx Pharmaceutical position peaked at $1.15M in Q2 2023.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.